Formulation of saRNA of Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
A self-assembly process was used to encapsulate saRNA in LNP, where an aqueous solutiom of saRNA at ph = 4.0 is rapidly mixed with an ethanol lipid mixture.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Vectors of Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
In vitro transcription of RNA of Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Animal and immunizations of Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Identification of immunogenicity of Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Recovered COVID-19 patient samples of Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice